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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of global disease burden. Although stroke was
thought to be more prevalent than coronary heart disease (CHD) in Chinese, the epidemic pattern might have
been changed in some rural areas nowadays. This study was to estimate up-to-date prevalence of CVD and its risk
factors in rural communities of Fangshan District, Beijing, China.
Methods: A cross-sectional population survey was carried out by stratified cluster sampling. A total of 58,308 rural
residents aged over 40 years were surveyed by face-to-face interview and physical examination during 2008 and
2010. The standardized prevalence was calculated according to adult sample data of China’s 5th Population Census
in 2000, and the adjusted prevalence odds ratio (POR) was calculated for the association of CHD/stroke with its
cardiovascular risk factors in multivariate logistic regression models.
Results: Age- and sex-standardized prevalence was 5.6% for CHD (5.2% in males and 5.9% in females), higher than
the counterpart of 3.7% (4.7% in males and 2.6% in females) for stroke. Compared with previous studies, higher
prevalence of 7.7%, 47.2%, 53.3% in males and 8.2%, 44.8%, 60.7% in females for diabetes, hypertension and
overweight/obesity were presented accordingly. Moreover, adjusted POR (95% confidence interval) of diabetes,
obesity, stage 1 and stage 2 hypertension for CHD as 2.51 (2.29 to 2.75), 1.53 (1.38 to 1.70), 1.13 (1.02 to 1.26) and
1.35 (1.20 to 1.52), and for stroke as 2.24 (1.98 to 2.52), 1.25 (1.09 to 1.44), 1.44 (1.25 to 1.66) and 1.70 (1.46 to 1.98)
were shown respectively in the multivariate logistic regression models.
Conclusions: High prevalence of CVD and probably changed epidemic pattern in rural communities of Beijing,
together with the prevalent cardiovascular risk factors and population aging, might cause public health challenges
in rural Chinese population.
Background
Mortality and disease burden of cardiovascular disease
(CVD) is increasing globally; and with demographic
shifts, urbanization and changing lifestyles, the number
of people with high blood pressure, diabetes, obesity or
dyslipidemia may grow larger, suggesting a further
increase in CVD in the future [1]. China is also experi-
encing an epidemic of CVD during recent decades [2].
Coronary heart disease (CHD) and stroke, the two
major CVD types, are becoming the first and second
leading cause of death among adults in China nowadays.
Compared to Western people, different epidemiologic
pattern of CVD has long been observed in Chinese, for
example, stroke is thought to be more prevalent than
CHD in Chinese population, especially in rural areas
[3,4].
However, with China’s economic growth, population
aging, nutritional transition and urbanization, especially
in areas nearby metropolis such as Beijing, the epidemic
pattern of CVD and its major risk factors might have
been changed [5]. Since few recent population-based
studies concerning CHD and stroke prevalence are
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study was conducted in Fangshan District, a rural area
of Beijing, China. In addition, prevalence of cardiovascu-
lar risk factors in this study was also compared with
results from the InterASIA (The international collabora-
tive study of cardiovascular diseases of Asia) [6-8] and
the 2007 survey among suburban communities in Beij-
ing [5].
Methods
Study population
A cross-sectional population survey was carried out
from March 2008 through August 2010 in rural com-
munities of Fangshan District, which is located 45 km
southwest of downtown Beijing. Briefly, the inclusion
criteria for target population in this study are native per-
manent residents aged over 40 and lived in local com-
munities for at least 5 years. A stratified clustered
sampling method was employed. The total 22 regions of
Fangshan District were divided into three categories
according to geographic characteristics as mountainous
area (8 towns), hilly area (8 towns) and plain area (6
towns), and 50% towns were randomly sampled in each
part (Figure 1). Thus a total number of 76,544 rural
registered inhabitants in the selected towns were
enrolled.
This study was approved by the ethics committee of
Peking University Health Sciences Center and local
institutional review board. Written informed consent
was signed by each participant before data collection.
Participants with untreated conditions identified during
examination were referred to a primary healthcare pro-
vider. This study is baseline for the Fangshan/Family-
based Ischemic Stroke Study in China (FISSIC) program
[9].
Data collection
Data collection was conducted in the local community
healthcare centers in participant’s residential area. All
participants were interviewed in person by trained inves-
tigators to obtain information on demographic charac-
teristics and self-reported medical history including
CHD, stroke, diabetes and hypertension using a struc-
tured questionnaire (Additional file 1). Then medical
records review regarding CHD and stroke were verified
by cardiologists and neurologists from the FISSIC pro-
gram central hospital (the First Hospital of Fangshan
District) with patients’ records through medical chart
review, based on electrocardiography (ECG), computer-
ized tomography (CT) or magnetic resonance imaging
(MRI). According to diagnosis standardization from
World Health Organization CHD/Stroke Community
Figure 1 Geographic map of Fangshan District, Beijing, China. The spots symbols in the map of Fangshan District indicated the towns
selected in this cross-sectional study.
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history of language or physical dysfunction which had
been continued for more than 24 h and diagnosed using
CT or MRI; and CHD was defined as a history of angina
or hospitalization for myocardial infarction with ECG
findings, or a surgical history of coronary balloon angio-
plasty, coronary artery bypass or coronary stent implan-
tation. In addition, medical history of diabetes was
defined as self-reported current treatment with insulin
or oral hypoglycemic agents.
Physical examination
During the physical examination, blood pressure was
measured at right brachial artery, using standard mer-
cury sphygmomanometers, by qualified physicians or
nurses after the participant having been resting in a
seated position for at least 5 min before each measure-
ment. Three blood pressure measurements were
obtained from each participant according to a common
protocol adapted from procedures recommended by the
American Heart Association [12], and the average values
were used for analysis. Anthropometric measurements
were also obtained by trained and certified observers.
Height was measured without shoes by a fixed stadi-
ometer and weight without heavy clothing by traditional
scales.
Criteria for data interpretation
Hypertension was defined as systolic blood pressure
(SBP) ≥ 140 mmHg, or diastolic blood pressure (DBP) ≥
90 mmHg, or current use of any antihypertensive medi-
cation within 2 weeks or any combination of the above.
Blood pressure category was used according to the
Seventh Joint National Committee on the Prevention,
Detection, Evaluation and Treatment of Hypertension
(JNC-7) [13] to classify blood pressure into normoten-
sion (SBP < 120 mmHg and DBP < 80 mmHg), prehy-
pertension (SBP of 120-139 mmHg or DBP of 80-89
mmHg), stage 1 hypertension (SBP of 140-159 mmHg
or DBP of 90-99 mmHg) and stage 2 hypertension (SBP
≥ 160 mmHg or DBP ≥ 100 mmHg). Body mass index
(BMI) was calculated as the ratio of weight to height
squared (kg/m
2). Overweight was defined as BMI ≥ 25
kg/m
2 and obesity as BMI ≥ 30 kg/m
2.
Statistical analysis
Data analyses were performed using the Statistical Ana-
lysis System version 9.1 (SAS Institute Inc., Cary, NC,
USA). Continuous measures were expressed as mean ±
standard deviation, and other categorical variables were
shown as counts and percentages. Prevalence data was
directly standardized to the adult sample data of 2000
China 5th Population Census and 2005 China popula-
tion for comparison [14]. For each gender, prevalence
was standardized using the same age distribution. 95%
confidence intervals of prevalence were calculated with
PROC SURVEYFREQ from the SAS statistical package.
Differences in demographic and anthropometric charac-
teristics, and comparison of age-specific prevalence data
between two gender groups were analyzed by t test and
Chi-square test. The prevalence odds ratio (POR) of car-
diovascular risk factors with CHD/stroke was calculated
in multivariate logistic regression models, adjusted for
age and sex. All tests for statistical significance were
two-sided and the significance level was set as a = 0.05.
Results
A total number of 58,308 rural residents (20,362 males
and 37,946 females) participated in our study with a
response rate of 76.2%. According to the residential geo-
graphic classification, 12.0% of participants were living
in mountainous areas, 43.5% in hilly areas and 44.5% in
plain areas, with mean ages of 58.0 ± 11.2, 55.9 ± 9.9
and 56.2 ± 9.6 years. All participants were classified into
10 years age bands: 40-49 years, 50-59 years, 60-69
years, 70-79 years, 80 years and above, and the numbers
(proportion) for each group were 16,767 (28.8%), 21,308
(36.5%), 13,560 (23.3%), 5,755 (9.9%) and 918 (1.6%),
respectively. General characteristics of the study partici-
p a n t sw e r es h o w ni nT a b l e1 .C o m p a r e db ys e x ,t h e
average levels for SBP, DBP, weight and height, and pre-
valence of hypertension were higher among males, while
the counterparts of BMI, diabetes, obesity and over-
weight were higher in females conversely (all P <0 . 0 5 ) .
More detailed data was provided in Additional file 2.
In participants aged above 40 of this study, overall
crude record-verified self-reported prevalence of CHD
and stroke was 6.1% (95% CI, 5.5%-6.8%) and 3.7% (95%
CI, 3.4%-4.0%), respectively. After directly standardized
to data from 2000 China 5th Population Census, the
standardized prevalence of CHD was 5.6% (5.2% in
males and 5.9% in females), which was higher than that
of stroke as 3.7% (4.7% in males and 2.6% in females)
(Table 2). Concerning different age groups, there were
similar increased trends of age-specific prevalence with
age growing for both CHD and stroke either in men or
women. In addition, directly standardized prevalence in
participants over 65 years was 10.9% for CHD (9.1% in
males and 12.5% in females) and 6.9% for stroke (8.3%
in males and 5.6% in females), which was much higher
than the counterpart in the group below 65 years (4.1%
for CHD and 2.8% for stroke) (Figure 2). With respect
to diabetes, hypertension, overweight and obesity, the
profile of standardized prevalence and the age-specific
prevalence were also displayed in Table 2, while their
crude prevalence were 8.6%, 47.2%, 43.2% and 15.1%,
respectively. Compared by sex, prevalence of hyperten-
sion was higher in males (P = 0.04), while that of
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(all P < 0.001).
Besides results in our study, a set of previous nation-
wide data from the 2000-2001 InterASIA study and data
from 2007 survey among suburban communities in
Beijing, which were also directly standardized to the
2000 China population, were compared in Figure 3.
From this comparison, higher prevalence for diabetes,
hypertension and overweight/obesity were observed
among males and females in both suburban and rural
Table 1 Characteristics of the study participants in Fangshan District, Beijing, China
Characteristics Total Males Females P value*
(N = 58,308) (N = 20,362) (N = 37,946)
Age (years), (mean ± SD) 56.3 ± 9.9 57.1 ± 10.2 55.9 ± 9.8 < 0.001
SBP (mmHg), (mean ± SD) 133.9 ± 17.9 134.4 ± 17.6 133.6 ± 18.0 < 0.001
DBP (mmHg), (mean ± SD) 84.1 ± 10.4 85.1 ± 10.8 83.6 ± 10.2 < 0.001
Weight (kg), (mean ± SD) 67.4 ± 11.4 71.6 ± 11.7 65.3 ± 10.6 < 0.001
Height (cm), (mean ± SD) 160.3 ± 7.9 167.2 ± 6.4 156.6 ± 5.9 < 0.001
BMI (kg/m
2), (mean ± SD) 26.2 ± 3.8 25.5 ± 3.6 26.6 ± 3.9 < 0.001
BP classification (%), (95% CI) < 0.001
Normotension 19.3 (16.6, 23.1) 17.8 (15.2, 20.9) 20.7 (17.4, 24.4) -
Prehypertension 37.8 (36.0, 39.7) 37.7 (35.9, 39.6) 37.9 (36.0, 39.9) -
Stage 1 hypertension 28.6 (26.3, 30.9) 29.2 (27.1, 31.4) 28.2 (25.8, 30.7) -
Stage 2 hypertension 13.9 (12.0, 16.1) 15.2 (13.2, 17.5) 13.2 (11.4, 15.3) -
Hypertension (%), (95% CI) 47.2 (44.5, 49.9) 48.7 (45.6, 51.8) 46.4 (43.8, 49.1) 0.004
Diabetes (%), (95% CI) 8.6 (7.4, 10.0) 7.8 (6.5, 9.3) 9.0 (7.8, 10.4) < 0.001
Overweight (%), (95% CI) 43.2 (41.7, 44.8) 41.2 (38.9, 43.7) 44.3 (43.1, 45.6) < 0.001
Obesity (%), (95% CI) 15.1 (13.8, 16.6) 10.7 (9.4, 12.1) 17.5 (16.0, 19.1) < 0.001
SBP systolic blood pressure; DBP diastolic blood pressure; BP blood pressure; BMI body mass index; SD standard deviation; CI confidence interval. BP classification:
normotension (SBP < 120 mmHg and DBP < 80 mmHg); prehypertension (SBP of 120-139 mmHg or DBP of 80-89 mmHg); stage 1 hypertension (SBP of 140-159
mmHg or DBP of 90-99 mmHg); stage 2 hypertension (SBP ≥ 160 mmHg or DBP ≥ 100 mmHg)
Hypertension was defined as SBP ≥ 140 mmHg, or DBP ≥ 90 mmHg, or current use of any antihypertensive medication within two weeks or any combination of
the above; diabetes was defined as self-reported current treatment with insulin or oral hypoglycemic agents; overweight was defined as BMI ≥ 25 kg/m
2 and
obesity as BMI ≥ 30 kg/m
2
*Compared between males and females
Table 2 Age- and sex-specific prevalence of cardiovascular diseases and risk factors among participants (%, and its
95% confidence interval)
Groups Coronary heart disease Stroke Diabetes Hypertension Overweight Obesity
Total
# 5.6 (4.8, 6.5) 3.7 (3.1, 4.4) 8.0 (6.6, 9.6) 46.1 (42.7, 49.4) 42.8 (40.6, 45.0) 14.1 (12.5, 16.0)
Males
40-49 2.8 (2.5, 3.0) 2.2 (1.9, 2.5) 7.9 (6.9, 9.2) 40.6 (37.5, 43.7) 45.6 (43.2, 47.9) 15.0 (13.5, 16.6)
50-59 5.2 (4.3, 6.1) 5.1 (4.7, 5.4) 8.7 (7.2, 10.6) 47.3 (43.6, 51.0) 43.3 (40.5, 46.1) 11.1 (9.7, 12.7)
60-69 7.7 (6.9, 8.5) 7.7 (6.9, 8.5) 7.7 (6.3, 9.3) 53.8 (51.0, 56.7) 39.6 (36.8, 42.5) 8.1 (6.7, 9.7)
70-79 9.7 (8.2, 11.4) 8.4 (7.3, 9.7) 5.3 (4.1, 6.7) 59.2 (56.0, 62.3) 31.2 (29.2, 33.3) 6.3 (5.1, 7.9)
≥80 9.8 (7.3, 13.0) 7.4 (4.8, 11.2) 5.3 (3.5, 7.8) 59.0 (54.3, 63.5) 24.9 (23.0, 26.8) 5.0 (3.4, 7.3)
Overall* 5.2 (4.4, 6.1) 4.7 (4.1, 5.6) 7.7 (6.3, 9.4) 47.2 (43.6, 50.8) 41.8 (39.1, 44.5) 11.5 (10.0, 13.3)
Females
40-49 2.1 (1.8, 2.5) 0.7 (0.6, 0.9) 4.9 (4.2, 5.6) 33.9 (31.2, 36.8) 45.5 (44.6, 46.5) 16.6 (15.2, 18.2)
50-59 5.2 (4.5, 5.9) 2.4 (2.1, 2.7) 9.5 (8.3, 10.7) 45.4 (42.3, 48.6) 46.6 (45.3, 47.8) 18.9 (17.1, 20.8)
60-69 10.6 (9.9, 11.3) 4.7 (4.0, 5.5) 13.5 (11.4, 15.8) 56.8 (54.0, 59.5) 42.7 (41.2, 44.3) 18.6 (16.8, 20.5)
70-79 12.9 (11.3, 14.8) 5.8 (4.8, 6.9) 10.0 (8.0, 12.5) 63.5 (61.3, 65.6) 37.1 (34.9, 39.4) 13.4 (12.0, 15.1)
≥80 15.0 (12.9, 17.4) 5.9 (3.9, 8.9) 8.3 (6.4, 10.8) 61.7 (56.9, 66.2) 30.0 (25.2, 35.3) 8.3 (5.8, 11.9)
Overall* 5.9 (5.1, 6.9) 2.6 (2.1, 3.1) 8.2 (7.0, 9.7) 44.8 (41.7, 47.9) 43.8 (42.2, 45.4) 16.9 (15.2, 18.8)
Hypertension was defined as SBP ≥ 140 mmHg, or DBP ≥ 90 mmHg, or current use of any antihypertensive medication within 2 weeks or any combination of
the above; diabetes was defined as self-reported current treatment with insulin or oral hypoglycemic agents; overweight was defined as BMI ≥ 25 kg/m
2 and
obesity as BMI ≥ 30 kg/m
2
#Directly standardized to the adult sample data of 2000 China 5th Population Census
*Both genders were age-standardized using the same age distribution from entire adult sample data of 2000 China 5th Population Census
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Page 4 of 10Figure 2 Standardized prevalence of CHD and stroke among adult population over 65 years and below 65 years in Fangshan District.
Prevalence for all participants was directly standardized to the adult sample data of 2000 China 5th Population Census; Prevalence by genders
was age-standardized using the same age distribution from entire adult sample data of 2000 China 5th Population Census.
Figure 3 Comparison of prevalence of diabetes, hypertension and overweight/obesity among males and females in the 2000-2001
InterASIA study, the 2007 survey in suburban of Beijing, and the 2008-2010 survey in rural Beijing. All the data were directly
standardized to the adult sample data of 2000 China 5th Population Census.
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Page 5 of 10Beijing recently, and even higher in the rural population,
especially for overweight/obesity in both sexes. Further-
more, in order to compare with the latest nationwide
diabetes prevalence from the 2007-2008 China National
Diabetes and Metabolic Disorders Study, the standar-
dized prevalence of diabetes in our study was calculated
as 8.0% overall (7.6% in males and 8.3% in females)
based on the 2005 China population.
Among different geographic areas in our study, from
mountainous area, hilly area to plain area, with the alti-
tude descending, decreased prevalence of CHD/stroke
and increased prevalence of obesity were shown in Fig-
ure 4(a-b, f). However, the diversity of CHD prevalence
in men was not as obvious as in women. Moreover,
compared with mountainous area, higher prevalence of
diabetes (Figure 4c), hypertension (Figure 4d) and
Figure 4 (a-f) Standardized prevalence of CHD (a), stroke (b), diabetes (c), hypertension (d), overweight (e) and obesity (f) by
geographic area among adult population older than 40 years in Fangshan District. Prevalence for all participants was directly standardized
to the adult sample data of 2000 China 5th Population Census; Prevalence by genders was age-standardized using the same age distribution
from entire adult sample data of 2000 China 5th Population Census.
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and plain area.
The adjusted PORs of diabetes, hypertension and
overweight/obesity with CHD/stroke were shown in
Table 3. Statistical analysis rejected the hypothesis of no
association between diabetes and CHD (POR = 2.51,
95% CI, 2.29-2.75; P < 0.001) or stroke (POR = 2.24,
95% CI, 1.98-2.52; P < 0.001). These results indicated
significantly that participants with diabetes took more
risks of both CHD and stroke. In addition, increased
risks for CHD and stroke were also presented in those
with overweight/obesity and in persons with hyperten-
sion (P < 0.01); however, hypertension in each stage
indicated higher risk for stroke than for CHD.
Discussion
T h ep r e s e n ts t u d yp r o v i d e du p - t o - d a t ep r e v a l e n c eo f
CVD and its major risk factors among rural adults aged
above 40 in Beijing. As one of the strengths, a large
community-based stable population was recruited, and
the elderly beyond 85 years, who were ignored by most
studies, were also included for its highest CVD inci-
dence rate. Furthermore, to enhance the comparability
with previous studies, age- and sex-standardized data
based on both China population 2000 and 2005 were
also provided. In addition, standard protocols and
instruments were used, and strict training and a vigor-
ous quality assurance program were conducted to
ensure that high-quality data were collected for this
study.
The main results of this study demonstrated highly
prevalent CHD and stroke in rural areas around a large
and fast developing city. Despite lack of data on CHD
prevalence, there were several prevalence reports on
stroke available for comparison. Previous nationwide
s t u d i e si nC h i n ah a dg i v e nas t r o k ep r e v a l e n c er a t eo f
0.53% for people aged over 45 years in the 1980s, with
higher prevalence in northern cities, such as Beijing,
than in the south [15,16]. However, at the very begin-
ning of this century, from National Nutrition and Health
Survey, an standardized stroke prevalence of 1.11%
(1.26% in male versus 0.96% in female, 1.47% in the
north versus 0.72% in the south, and 1.54% in urban
versus 0.76% in rural) was reported in general Chinese
population aged over 35 years in 2002 [17], which, in
spite of being conducted in a relatively younger popula-
tion, showed an obviously increased stroke prevalence in
the past two decades. To add more evidence to the
increased trends of CVD, our study provided recent
stroke prevalence overall (3.7%), in male (4.7%) and in
female (2.6%), which were higher than results of pre-
vious studies above, and CHD prevalence (5.6% overall,
5.2% in male and 5.9% in female) in a rural population
aged beyond 40 living in North China. CHD and stroke
prevalence in China are to some extent indicated to be
in trends of rising, and are probably more prominent in
northern area. More important, the rural areas around
big cities might have been overwhelmed by CVD
burden.
Furthermore, a probably changed pattern of CVD pre-
valence in rural Chinese was presented by the current
study. Compared to Western populations, stroke was
used to be regarded more common than CHD in Chi-
nese population, especially for rural residents [18,19].
This impression mostly stemmed from the much higher
incidence and mortality of stroke than that of CHD
based on the Sino-MONICA project conducted from
1987 to 1993, which was one part of WHO MONICA
Table 3 Adjusted associations between coronary heart disease/stroke and cardiovascular risk factors
Variables Coronary heart disease Stroke
Prevalence Odds Ratio (95% CI) P Value Prevalence Odds Ratio (95% CI) P Value
Diabetes 2.51 (2.29, 2.75) < 0.001 2.24 (1.98, 2.52) < 0.001
BP classification
Normotension Reference - Reference -
Prehypertension 1.04 (0.93, 1.15) 0.505 1.16 (1.01, 1.33) 0.043
Stage 1 hypertension 1.13 (1.02, 1.26) < 0.001 1.44 (1.25, 1.66) < 0.001
Stage 2 hypertension 1.35 (1.20, 1.52) < 0.001 1.70 (1.46, 1.98) < 0.001
Weight classification
Normal weight Reference - Reference -
Overweight 1.28 (1.19, 1.39) < 0.001 1.20 (1.09, 1.33) < 0.001
Obesity 1.53 (1.38, 1.70) < 0.001 1.25 (1.09, 1.44) 0.001
BP Blood Pressure; CI confidence interval. BP classification: normotension (SBP < 120 mmHg and DBP < 80 mmHg); prehypertension (SBP of 120-139 mmHg or
DBP of 80-89 mmHg); stage 1 hypertension (SBP of 140-159 mmHg or DBP of 90-99 mmHg); stage 2 hypertension (SBP ≥ 160 mmHg or DBP ≥ 100 mmHg)
Diabetes was defined as self-reported current treatment with insulin or oral hypoglycemic agents; overweight was defined as BMI ≥ 25 kg/m
2 and obesity as BMI
≥ 30 kg/m
2
Prevalence odds ratios were calculated with the use of multivariate logistic regression models. All variables listed were included in the model simultaneously,
adjusted by age and sex
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Determination in Cardiovascular Disease) project [20].
In the Sino-MONICA project, 7 years surveillance in
Beijing indicated incidence and mortality from stroke
were 3 times and 1.5 times those of CHD, which would
have led to more people with stroke be accumulated
than those with CHD, so that higher stroke prevalence
would have been observed nowadays. Nevertheless, our
study indicated a result of higher CHD prevalence
(5.6%) than stroke prevalence (3.7%) recently, which
might change the previous knowledge about pattern of
CVD in China. Despite lack of comparable data in
China and other Asian countries, studies in Japan added
evidence to increased incidence and declined mortality
for CHD and also declined incidence of stroke in both
urban and rural Japanese communities [21,22]. Consid-
ering incidence and mortality as two critical factors of
prevalence rate, these evidences above suggested a dis-
tinctive transition that much heavier burden of CHD
might have already existed in Asian countries with a
CVD pattern similar to Western countries.
To further describe the CVD epidemic pattern in rural
Beijing, data for prevalence of its major risk factors,
including diabetes, hypertension and overweight/obesity,
were also collected in our study. Hypertension, as an
important risk factor of CVD, was found to be highly
prevalent among adults in Fangshan District, with much
higher prevalence than results from the 2000-2001
InterASIA study [8]. Moreover, a set of increased odds
ratios for different blood pressure categories from pre-
hypertension to stage 2 hypertension were also shown
to be associated with CHD/stroke, which suggested peo-
ple with higher blood pressure would be at more risk.
In addition, the differences of odds ratios for CHD and
stroke indicated a closer relationship between hyperten-
sion and stroke, which supported the notion from the
INTERSTROKE study published recently [23]. Thus, the
prevalent hypertension might contribute to explain rela-
tively high stroke prevalence in rural Chinese. Besides
hypertension, diabetes and obesity are also important
risk factors of CVD. Although diabetes prevalence in
our study was lower than the 2007-2008 China National
Diabetes and Metabolic Disorders Study (9.7% in total,
10.6% in males and 8.8% in females) [24], its actual pre-
valence in Fangshan District might be higher, due to
lower awareness of diabetes in rural population in China
[25]. The prevalence of overweight and obesity in this
study were much higher than national level in 2000-
2001 [7]; however, together with other previous evidence
[26], this transition reflected the strikingly increase of
obesity and might lead to prevalent CHD in China sub-
sequently. Furthermore, prevalence of CVD risk factors
in our study was also higher than their counterpart in
suburban of Beijing, from a cross-sectional survey in
2007 [5]. Through this comparison, CVD risk factors
w e r ef o u n dt ob em o r ec o m m o ni nr u r a lB e i j i n g ,a n d
t h er e m a r k a b l eo v e r w e i g h t / o b e s i t yp r e v a l e n c ep r o b a b l y
has a close relationship with nutritional transition in
Chinese as previous study indicated [27].
Although it is not the main focus of the study and
lack of data from similar researches to compare with, an
interesting finding is the diversity in the distribution of
CVD and its risk factors across three different geo-
graphic areas. Diabetes, hypertension, overweight and
obesity prevalence were illustrated to be lower in moun-
tainous area compared with either hilly or plain area,
which seemed to be a contradiction with the higher pre-
v a l e n c eo fC H Da n ds t r o k et h e r e .I tm a yh i g h l i g h tt h e
importance of other risk factors which were temporarily
not explored in our study, such as smoking, family his-
tory and lipid profiles. Moreover, it probably also attri-
bute to the inconvenient transportation and low socio-
economic status in mountainous area: on the one hand,
many labors free of diseases moved from mountainous
to plain area, while the sick stayed at home; on the
other hand, the poorer medical condition and education
level in mountainous area led to the lower awareness of
CVD risk factors. Hence lower awareness, treatment and
control of CVD risk factors in mountainous area would
possibly aggravate the CHD/stroke epidemic.
Besides the major risk factors described above, popula-
tion aging might be another important force driving the
increase of CVD prevalence. It was forecasted that CHD
incidences and deaths in China would increase dramati-
cally over 2010-2029, due to population growing and
aging alone [28]. Furthermore, the elder population is
usually suffering much higher CVD prevalence.
Although few data on CHD prevalence for the elders
w a sp u b l i s h e ds of a r ,t h e r ew e r es t i l laf e wr e l i a b l e
stroke reports. In some developed countries, the stroke
prevalence for people aged 65 years and above ranged
from 4.61% to 7.33% (directly standardized to the Segi
1996 world population) [29]. During 2005 national sur-
vey in the United States, 8.1% of persons aged 65 years
and above reported they had had a history of stroke,
whereas the proportion in population aged 45-64 years
is 2.7% [30]. In Asia, recent study also pointed out a
high prevalence of 10.2% for stroke in residents older
than 65 in Korea (directly standardized to the 2005 Kor-
ean population) [31]. To make complements, our study
provided standardized prevalence of 10.9% for CHD and
6.9% for stroke among participants 65 years and above,
much higher than 4.1% for CHD and 2.8% for stroke
among individuals below 65 years (directly standardized
to the adult sample data of 2000 China 5th Population
Census); and this disparity was even greater in female.
Moreover, a higher prevalence of CHD in females aged
65 and above than males was presented in our results,
He et al. BMC Public Health 2012, 12:34
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and probably seemed to be contrary to the common
ideas; however an earlier population-based study con-
ducted in Hong Kong also reported a much higher
CHD prevalence of 9.7% in Chinese women aged 65-74
years than men (5.1%) [32], which was consistent with
our study. World population is aging and this has
already made a considerable impact on the CVD burden
in developed countries in recent decades. It is reason-
able to suppose that, as the age structure of the Chinese
population increases, the CVD burden in China will be
aggravated and might be different by genders.
Urbanization should also be considered as a rational
reason to explain higher prevalence of CVD and its risk
factors in rural population [24,33]. Though China has
the largest population in developing countries with an
unbalanced development throughout the whole country,
the westernization of lifestyles is accelerated not only
among urban residents but also among rural population,
especially for the ones nearby modern region [33]. Fang-
shan District is a typical rural area in the southwest of
Beijing, one of the most modernized cities in China, and
it might probably be suffered by a high burden of CVD.
Thus, taken in this sense, our results may have further
public health implications.
Several limitations in our study should be addressed.
Firstly, it was a cross-sectional study which could not
tell the true relationship between cardiovascular risk fac-
tors and CVD. However, it has already been demon-
strated in Chinese adults by previous studies [34].
Secondly, twice as many women as men were investi-
gated, probably because part of young and male labor
force that went to work in big cities was unavailable for
this survey, which is a common problem in rural China.
Thirdly, estimation of CHD and stroke prevalence was
mainly based on record-verified self-reported data. On
the one hand, local general practitioners, who were
familiar with health issues of their patients in the ser-
ving communities, participated in the investigation to
decrease under-reporting level; on the other hand, in
order to avoid over-reporting, qualified cardiologists and
neurologists were also joined to confirm the diagnosis of
diseases through medical record review. Finally, rela-
tively limited information was collected for this large
population in the initial baseline, but more detailed
information such as surveillance data, life-style risk fac-
tors and lipid profiles were scheduled to be added in the
next stage as well, so the findings in this study may pro-
vide clues for further investigations.
Conclusions
In summary, this population-based survey indicated a
high prevalence of CVD and the probably changed epi-
demic pattern in Fangshan District, a rural area of
Beijing, China. High prevalence of cardiovascular risk
factors and population aging might aggravate the burden
brought by CVD and become a public health concern in
developing rural areas.
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